Qualigen Therapeutics Inc (QLGN)
4.10
-0.08
(-1.84%)
USD |
NASDAQ |
Nov 14, 12:12
Qualigen Therapeutics Total Liabilities (Quarterly): 4.812M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 4.812M |
| March 31, 2024 | 4.525M |
| December 31, 2023 | 4.137M |
| September 30, 2023 | 5.957M |
| June 30, 2023 | 9.842M |
| March 31, 2023 | 9.714M |
| December 31, 2022 | 10.32M |
| September 30, 2022 | 7.043M |
| Date | Value |
|---|---|
| June 30, 2022 | 7.879M |
| March 31, 2022 | 5.192M |
| December 31, 2021 | 6.271M |
| September 30, 2021 | 5.558M |
| June 30, 2021 | 7.627M |
| March 31, 2021 | 9.505M |
| September 30, 2020 | 23.56M |
| June 30, 2020 | 21.83M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.137M
Minimum
Dec 2023
23.56M
Maximum
Sep 2020
8.986M
Average
7.335M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 9.613M |
| IGC Pharma Inc | 2.714M |
| NovaBay Pharmaceuticals Inc | 4.542M |
| Protalix BioTherapeutics Inc | 62.96M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.5344M |
| Shareholders Equity (Quarterly) | -4.278M |